3.00
-0.01(-0.33%)
Currency In USD
| Previous Close | 3.01 |
| Open | 3.02 |
| Day High | 3.02 |
| Day Low | 3 |
| 52-Week High | 6.27 |
| 52-Week Low | 2 |
| Volume | 554 |
| Average Volume | 709,090 |
| Market Cap | 13.72M |
| PE | -3.61 |
| EPS | -0.83 |
| Moving Average 50 Days | 3.23 |
| Moving Average 200 Days | 2.85 |
| Change | -0.01 |
If you invested $1000 in Amesite Inc. (AMST) since IPO date, it would be worth $47.89 as of November 11, 2025 at a share price of $3. Whereas If you bought $1000 worth of Amesite Inc. (AMST) shares 3 years ago, it would be worth $1,034.48 as of November 11, 2025 at a share price of $3.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Amesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plans for Coming Months
GlobeNewswire Inc.
Oct 30, 2025 10:30 AM GMT
Shareholder Update Reports Positive Customer Reviews, New Segment Growth and Technology Rollouts across Post-Acute HealthcareDETROIT, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise soluti
Amesite Reports 63% Revenue Growth from NurseMagic™ Enterprise; Announces Launch of AI-Powered Government Form-Fill Automation to Reduce Reporting Burden
GlobeNewswire Inc.
Sep 11, 2025 10:30 AM GMT
DETROIT, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced 63% revenue growth for its NurseMagic™ platform following the launch of its census-based Enterprise sub
Amesite Launches Census-Based Enterprise Tier for NurseMagic™ to Drive Revenue Growth and Meet Enterprise Demand, Significantly Expanding Total Addressable Market
GlobeNewswire Inc.
Jul 14, 2025 10:30 AM GMT
New Tier Adds EMR Integration, Team Reporting (IDT) and Custom Form Support — Enabling Scalable Deployment Across Entire Patient CensusDETROIT, July 14, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterpr